In fact, they found that two out of three patients (66.8%) at 1 year, and 42.9% of patients at 2 years, did not require a change in their strategy even if it did not reach statistical significance, but a trend is clearly visible.
← all excerpts
Stereotactic Body Radiation Therapy (SBRT) for Oligorecurrent/Oligoprogressive Mediastinal and Hilar Lymph Node Metastasis: A Systematic Review.
1
—
—